Focal Vibration on the Performance of Amateur Athletes
Effectiveness of Focal Vibration on the Performance of Amateur Athletes
1 other identifier
interventional
70
1 country
1
Brief Summary
Focal vibration is an adjustable instrument, which has the ability to apply vibration to a specific point at different hertz, powers and rhythms. The use of general or focused vibration is not new in the rehabilitation or sports field. Vibration is intended to stimulate neuromuscular uses to produce involuntary and additional contractions of muscle tissue, indirectly causing an increase in strength or muscle mass , improved fall prevention, mobility and bone consolidation. This type of device has been used both in athletes and in patients with chronic diseases or in intensive care units. There are studies that use vibration in critically ill patients because it is a safe and feasible intervention for dependent patients. One of the advantages of focal vibration is that it can be used in both unloading and loading, which allows a wide range of adaptation to each patient, even simultaneously during a training activity. The aim of the present study is to evaluate the effectiveness of a focal vibration treatment on strength, jumping and running speed in national federated athletes who perform sprinting and jumping in their sports practice. A sample will be recruited during the months of April to September, estimating a sample of 70 total subjects (35 subjects in the vibration group and 35 subjects in the vibration placebo group). Patients will receive a single treatment and assessments will be performed on the same day. The focal vibration group will receive a 30-minute quadriceps intervention. 3 channels will be used on the muscle bellies of the rectus anterior, vastus internus and vastus externus. The vibration program configuration will be in an automatic mode of 10 seconds of vibration 3 seconds of rest to avoid mechanoreceptor coupling. The frequency used will be between 60 Hz to 150 Hz with a power of 80%. The placebo group will perform the same treatment as the intervention group but without the focal vibration head contacting the skin (placebo). A sufficient space will be left between the head and the headgear so that the vibration does not touch the skin as shown in previous studies. A V-Plus machine (Wintecare S.A.) will be used for the vibration treatment. For the assessment measurements, a surface electromyograph, a force measurement dynamometer, the MyJump2 application for jump assessment and two photoelectric cells for sprint measurement will be used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2023
CompletedStudy Start
First participant enrolled
March 1, 2023
CompletedFirst Posted
Study publicly available on registry
March 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedMarch 7, 2023
February 1, 2023
1 month
February 23, 2023
March 6, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Change in 30 meters sprint (seconds)
Photoelectric cells will be used to measure the time required to complete a 30-meter sprint.
Baseline(immediately before intervention) and post intervention (immediately after intervention)
Changes in electromyographic activity during sprint (μ/v)
The mean electromyographic activity of the quadriceps musculature during sprint will be measured with The mDurance® system device (mDurance Solutions SL, Granada, Spain).
Baseline(immediately before intervention) and post intervention (immediately after intervention)
Secondary Outcomes (4)
Countermovement jump (cm)
Baseline(immediately before intervention) and post intervention (immediately after intervention)
Changes in electromyographic activity during countermovement jump (μ/v)
Baseline(immediately before intervention) and post intervention (immediately after intervention)
Changes in isometric leg extension (Newtons)
Baseline(immediately before intervention) and post intervention (immediately after intervention)
Changes in electromyographic activity during isometric leg extension (μ/v)
Baseline(immediately before intervention) and post intervention (immediately after intervention)
Study Arms (2)
Focal Vibration Group
EXPERIMENTALSham Group
SHAM COMPARATORInterventions
A single 30-minute focal vibration procedure will be performed on both quadriceps with the V-Plus Wintecare® machine. Three channels will be used on the muscle bellies of the rectus anterior, vastus internus and vastus externus. The positioning of the vibration heads will be done with straps designed by the manufacturer to keep the vibration focus stable on the muscle belly. The configuration of the vibration program will be in an automatic mode of 10 seconds of vibration and 3 seconds of rest to avoid the coupling of the mechanoreceptors. The frequency used will be between 60 Hz to 150 Hz with a power of 80%.
The same procedure of the intervention group will be performed but without the focal vibration head contacting the skin (sham). A sufficient space will be left between the head and the headgear so that the vibration does not touch the skin.
Eligibility Criteria
You may qualify if:
- Athletes between 18 and 30 years of age (athletics and field sports such as soccer, basketball, rugby... that may involve sprinting) federated and competing in university or national amateur leagues that perform sprinting and jumping in their sports practice.
- Active participation in regional, national or international competitions.
You may not qualify if:
- Volunteers who have suffered a sports injury during the last two months or are unable to perform physical activity.
- Not understanding the information provided by the therapist.
- Participate in other research studies.
- Being under a pharmacological medical treatment that may interfere with the measures, such as treatment with anticonvulsants, antidepressants, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitat Internacional de Catalunya
Sant Cugat del Vallès, Barcelona, 08195, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 23, 2023
First Posted
March 7, 2023
Study Start
March 1, 2023
Primary Completion
April 1, 2023
Study Completion
April 1, 2023
Last Updated
March 7, 2023
Record last verified: 2023-02